INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 51 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $4,000 | -100.0% | 4,000 | -100.0% | 0.00% | -100.0% |
Q1 2021 | $22,755,000 | +4.8% | 27,701,000 | +1.1% | 0.49% | +5.8% |
Q4 2020 | $21,720,000 | -7.5% | 27,397,000 | -5.5% | 0.46% | -10.6% |
Q3 2020 | $23,479,000 | +9.2% | 28,978,000 | -0.2% | 0.52% | +2.8% |
Q2 2020 | $21,495,000 | -27.0% | 29,044,000 | -19.6% | 0.50% | -21.2% |
Q1 2020 | $29,433,000 | -35.0% | 36,111,000 | -19.1% | 0.64% | -27.0% |
Q4 2019 | $45,282,000 | +15.2% | 44,625,000 | -2.4% | 0.88% | +19.0% |
Q3 2019 | $39,322,000 | -14.0% | 45,740,000 | -10.7% | 0.74% | -16.7% |
Q2 2019 | $45,744,000 | -10.8% | 51,245,000 | -1.0% | 0.88% | -21.8% |
Q1 2019 | $51,281,000 | +140.3% | 51,747,000 | +123.8% | 1.13% | +119.2% |
Q4 2018 | $21,341,000 | -26.8% | 23,118,000 | -19.9% | 0.52% | -14.1% |
Q3 2018 | $29,171,000 | +32.9% | 28,863,000 | +15.0% | 0.60% | +30.1% |
Q2 2018 | $21,948,000 | +27.4% | 25,100,000 | +16.7% | 0.46% | +36.7% |
Q1 2018 | $17,230,000 | -11.8% | 21,513,000 | -11.9% | 0.34% | -9.6% |
Q4 2017 | $19,539,000 | +1.1% | 24,415,000 | -1.4% | 0.37% | +2.2% |
Q3 2017 | $19,323,000 | +158.8% | 24,766,000 | +222.1% | 0.37% | +155.9% |
Q2 2017 | $7,467,000 | +2.3% | 7,688,000 | -1.7% | 0.14% | +4.4% |
Q1 2017 | $7,302,000 | -12.3% | 7,823,000 | -15.7% | 0.14% | -10.5% |
Q4 2016 | $8,330,000 | -19.8% | 9,279,000 | -0.0% | 0.15% | +2.0% |
Q3 2016 | $10,387,000 | +0.8% | 9,281,000 | -7.2% | 0.15% | -5.7% |
Q2 2016 | $10,301,000 | – | 10,000,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERBACK ASSET MANAGEMENT LLC | 12,851,000 | $12,016,000 | 2.95% |
Context Capital Management, LLC | 3,000,000 | $2,804,000 | 2.24% |
Man Investments (CH) AG | 3,000,000 | $2,798,000 | 1.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,500,000 | $39,540,000 | 1.52% |
MACKAY SHIELDS LLC | 17,069,000 | $15,982,000 | 0.73% |
HIGHFIELDS CAPITAL MANAGEMENT LP | 73,035,000 | $68,425,000 | 0.63% |
WOLVERINE ASSET MANAGEMENT LLC | 42,307,000 | $39,554,000 | 0.61% |
LINDEN ADVISORS LP | 14,122,000 | $13,194,000 | 0.49% |
GLG LLC | 9,100,000 | $8,486,000 | 0.47% |
Jabre Capital Partners S.A. | 3,400,000 | $3,179,000 | 0.38% |